Christopher Boerner

New Capabilities

As of May 2026: Leading BMS through portfolio transition toward growth brands

For most of the past decade, people with psoriatic arthritis who wanted a pill had one real choice: Janus kinase (JAK) inhibitors. The FDA slapped those drugs with its strongest safety warning in 2021, after a major trial linked them to higher rates of heart attacks, blood clots, cancer, and death.

Updated May 30